Quantcast

Latest MRI contrast agent Stories

2012-10-09 04:00:48

The national class action lawyers at Glen Lerner Injury Attorneys announced that they are now reviewing potential gadolinium contrast claims for people with impaired kidneys who underwent a magnetic resonance image (MRI) scan that used a gadolinium contrast agent. These individuals may be at risk for developing Nephrogenic Systemic Fibrosis (NSF). Any individuals that suffer from kidney disease who have been exposed to a Gadolinium MRI contrast agent are encouraged to call 1 (800) GET-GLEN...

2012-05-02 11:42:41

Researchers at Harvard-affiliated McLean Hospital have shown a new category of "green" nanoparticles comprised of a non-toxic, protein-based nanotechnology that can non-invasively cross the blood brain barrier and is capable of transporting various types of drugs. In an article published May 1, 2012 online in PLoS ONE, Gordana Vitaliano, MD, director of the Brain Imaging NaNoTechnology Group at the McLean Hospital Imaging Center, reported that clathrin protein, a ubiquitous protein found...

2011-12-23 10:53:35

Many imaging technologies and their contrast agents – chemicals used during scans to help detect tumors and other problems – involve exposure to radiation or heavy metals, which present potential health risks to patients and limit the ways they can be applied. In an effort to mitigate these drawbacks, new research from University of Pennsylvania engineers shows a way to coat an iron-based contrast agent so that it only interacts with the acidic environment of tumors, making it...

2011-12-01 10:36:38

New research in the FASEB Journal suggests magnetic resonance imaging allows researchers to study and monitor how new vessels perform while they are 'under construction' in patients Using magnetic resonance imaging (MRI) and nanoparticle technology, researchers from Yale have devised a way to monitor the growth of laboratory-engineered blood vessels after they have been implanted in patients. This advance represents an important step toward ensuring that blood vessels, and possibly other...

2011-08-03 22:02:40

A single compound with dual function "“ the ability to deliver a diagnostic and therapeutic agent "“ may one day be used to enhance the diagnosis, imaging and treatment of brain tumors, according to findings from Virginia Commonwealth University and Virginia Tech. Glioblastomas are the most common and aggressive brain tumor in humans, with a high rate of relapse. These tumor cells often extend beyond the well-defined tumor margins making it extremely difficult for clinicians and...

2010-11-10 00:00:37

Spangenberg Shibley & Liber LLP attorneys Peter J. Brodhead, William Hawal and Peter H. Weinberger are representing numerous Nephrogenic Systemic Fibrosis patients in their lawsuits against GE Healthcare and its drug Omniscan. Cleveland, OH (PRWEB) November 9, 2010 On September 9, 2010 the FDA announced its decision to require changes to the labeling of gadolinium-based contrast agents (GBCAs) for use with patients with impaired kidney function who undergo MRI procedures. These changes...

2010-01-14 20:22:04

Dramatically enhanced image contrast could revolutionize diagnostics and therapeutics A Northwestern University study shows that coupling a magnetic resonance imaging (MRI) contrast agent to a nanodiamond results in dramatically enhanced signal intensity and thus vivid image contrast. "The results are a leap and not a small one -- it is a game-changing event for sensitivity," said Thomas J. Meade, the Eileen Foell Professor in Cancer Research in the Weinberg College of Arts and Sciences and...

2008-07-08 09:00:12

WAYNE, N.J., July 8 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc., a leader in diagnostic imaging, announced today that the U.S. Food and Drug Administration (FDA) has approved EOVIST(R) (Gadoxetate Disodium) Injection, a gadolinium-based contrast agent, for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease. The approval makes EOVIST the first organ-specific MRI...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.